Senior insider sale
Vice President, Finance at CYMABAY THERAPEUTICS, INC. — senior position signals high conviction
$3.72M
164K shares
What this filing means
MENOLD DANIEL plans to sell 164K shares of CYMABAY THERAPEUTICS, INC. valued at approximately $3.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/1/2024ACC: 0001972362-24-000061
Officer· Vice President, Finance
Since Aug 2018
164K
Shares to sell
$3.72M
Approx. market value
25K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
2/1/2024
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2024 | STOCK OPTION EXERCISE COMPENSATION | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
25K
Market value
$587.5K
1/30/2024
—Completed
Units to sell
45K
Market value
$1.06M
1/29/2024
—Completed
Units to sell
20K
Market value
$460.8K
1/26/2024
—Completed
Units to sell
10K
Market value
$235.8K
1/16/2024
—Completed
Units to sell
21.50K
Market value
$472.6K
12/15/2023
—Completed
Units to sell
17.50K
Market value
$304.1K
11/15/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
25K
Market value
$600.0K
2/1/2024
Total
Units
164K
Value
$3.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/30/2024 | 25K | $587.5K | — | Completed |
1/29/2024 | 45K | $1.06M | — | Completed |
1/26/2024 | 20K | $460.8K | — | Completed |
1/16/2024 | 10K | $235.8K | — | Completed |
12/15/2023 | 21.50K | $472.6K | — | Completed |
11/15/2023 | 17.50K | $304.1K | — | Completed |
| Planned — Approximate Date | ||||
2/1/2024 | 25K | $600.0K | NASDAQ | Planned |
| Total | 164K | $3.72M | ||